小林博人 (Hirohito Kobayashi) - マイポータル

基本情報

所属: 東京女子医科大学附属足立医療センター輸血・細胞治療部、泌尿器科准教授

学位: 博士（医学）(東京女子医科大学)

J-GLOBAL ID: 200901049525077923
researchmap会員ID: 5000100325

研究分野

ライフサイエンス / 免疫学 /

論文

Predictive factors for recurrence after complete metastasectomy in patients with metastatic renal cell carcinoma in the targeted therapy era.

Toshio Takagi, Hironori Fukuda, Hiroki Ishihara, Kazuhiko Yoshida, Tsunenori Kondo, Hirohito Kobayashi, Junpei Iizuka, Masayoshi Okumi, Hideki Ishida, Kenji Omae …

Urologic oncology 38(5) 515-520 2020年3月4日査読有り
Negative Effect of Immediate Sunitinib Interruption on Survival in Patients With Metastatic Renal Cell Carcinoma.

Ishiyama R, Ishihara H, Kondo T, Takagi T, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K

In vivo (Athens, Greece) 33(6) 2153-2160 2019年11月査読有り
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma.

Ishihara H, Tachibana H, Takagi T, Kondo T, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H …

Targeted oncology 14(4) 453-463 2019年8月査読有り
Association between tumor contact surface area and parenchymal volume change in robot-assisted laparoscopic partial nephrectomy carried out using the enucleation technique.

Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K

International journal of urology : official journal of the Japanese Urological Association 26(7) 745-751 2019年7月査読有り
Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.

Yoshida K, Takagi T, Kondo T, Kobayashi H, Iizuka J, Fukuda H, Ishihara H, Okumi M, Ishida H, Tanabe K

Japanese journal of clinical oncology 49(6) 576-580 2019年6月査読有り
Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.

Ishihara H, Takagi T, Kondo T, Homma C, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M …

Urologic oncology 37(6) 355.e21-355.e29 2019年6月査読有り
Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.

Takagi T, Fukuda H, Kondo T, Ishihara H, Yoshida K, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K

Targeted oncology 14(2) 179-186 2019年4月査読有り
Peritumoral pseudocapsule status according to pathological characteristics from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma.

Takagi T, Yoshida K, Kondo T, Kobayashi H, Iizuka J, Okumi M, Ishida H, Nagashima Y, Tanabe K

International journal of urology : official journal of the Japanese Urological Association 26(4) 446-450 2019年4月査読有り
Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H …

Medical oncology (Northwood, London, England) 36(4) 35-35 2019年3月査読有り
Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective Study.

Ishihara H, Kondo T, Takagi T, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Tanabe K

Targeted oncology 13(5) 611-619 2018年10月査読有り
Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma.

Takagi T, Yoshida K, Kobayashi H, Kondo T, Iizuka J, Okumi M, Ishida H, Fukuda H, Ishihara H, Tanabe K

Japanese journal of clinical oncology 48(9) 860-863 2018年9月査読有り
Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.

Kondo T, Sasa N, Yamada H, Takagi T, Iizuka J, Kobayashi H, Yoshida K, Fukuda H, Ishihara H, Tanabe K …

Pathology international 68(10) 543-549 2018年9月査読有り
Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-assisted Partial Nephrectomy.

Ishiyama R, Kondo T, Takagi T, Iizuka J, Kobayashi H, Omae K, Fukuda H, Ishihara H, Tanabe K

Journal of endourology 32(10) 928-933 2018年8月査読有り
Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Iwamoto K, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K

Japanese journal of clinical oncology 48(7) 667-672 2018年7月査読有り
Possible Application of Ascites-infiltrating Gamma-delta T Cells for Adoptive Immunotherapy.

Abe Y, Kobayashi H, Akizawa Y, Ishitani K, Hashimoto K, Matsui H

Anticancer research 38(7) 4327-4331 2018年7月査読有り
Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy

Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, Kazuhiko Yoshida, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe

International Journal of Clinical Oncology 23(3) 559-567 2018年6月1日査読有り
Comparison of Kidney Function in the Early Postoperative Period in Transperitoneal Robot-Assisted Laparoscopic Partial Nephrectomy Between Anterior and Posterior Renal Tumors: A Propensity Score-Matched Study

Toshio Takagi, Tsunenori Kondo, Kazuhiko Yoshida, Hirohito Kobayashi, Junpei Iizuka, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe

JOURNAL OF ENDOUROLOGY 32(2) 111-115 2017年12月査読有り
Evaluation of renal function change during first-line tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma

Hiroki Ishihara, Tsunenori Kondo, Hironori Fukuda, Kazuhiko Yoshida, Kenji Omae, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe

JAPANESE JOURNAL OF CLINICAL ONCOLOGY 47(12) 1175-1181 2017年12月査読有り
Comparison of Surgical Outcomes Between Resection and Enucleation in Robot-Assisted Laparoscopic Partial Nephrectomy for Renal Tumors According to the Surface-Intermediate-Base Margin Score: A Propensity Score-Matched Study

Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, Junpei Iizuka, Kenji Omae, Kazuhiko Yoshida, Hirohito Kobayashi, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe

JOURNAL OF ENDOUROLOGY 31(8) 756-761 2017年8月査読有り
Comparison of Surgical Outcomes between Resection and Enucleation in Robot-Assisted Laparoscopic Partial Nephrectomy for Renal Tumors According to the Surface-Intermediate-Base Margin Score: A Propensity Score-Matched Study

Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, Junpei Iizuka, Kenji Omae, Kazuhiko Yoshida, Hirohito Kobayashi, Masayoshi Okumi, Hideki Ishida, Kazunari Tanabe

Journal of Endourology 31(8) 756-761 2017年8月1日査読有り

もっとみる

MISC

IMPACT OF MAYO ADHESIVE PROBABILITY SCORE ON THE COMPLEXITY OF ROBOT-ASSISTED PARTIAL NEPHRECTOMY.

Ryo Ishiyama, Tsunenori Kondo, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Kenji Omae, Norihiro Fukuda, Hiroki Ishihara, Kazunari Tanabe

JOURNAL OF UROLOGY 197(4) E788-E788 2017年4月
COMPARISONS OF SURGICAL OUTCOMES BETWEEN THE RESECTION AND THE ENUCLEATION IN ROBOT ASSISTED LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR RENAL TUMORS ACCORDING TO THE SURFACE-INTERMEDIATE-BASE MARGIN SCORE

Toshio Takagi, Tsunenori Kondo, Junpei Iizuka, Hirohito Kobayashi, Hidekazu Tachibana, Kazuhiko Yoshida, Hideki Ishida, Kazunari Tanabe

JOURNAL OF UROLOGY 197(4) E649-E650 2017年4月
腎部分切除後腎動脈仮性動脈瘤発生のリスク因子の検討

高木敏男, 近藤恒徳, 大前憲史, 吉田一彦, 飯塚淳平, 小林博人, 橋本恭伸, 田邉一成

泌尿器外科 29(臨増) 884-884 2016年5月
ASSESSMENT OF SURGICAL OUTCOMES OF THE NON-RENORRHAPHY TECHNIQUE IN OPEN PARTIAL NEPHRECTOMY FOR=T1B RENAL TUMORS

Toshio Takagi, Tsunenori Kondo, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe

JOURNAL OF UROLOGY 195(4) E563-E563 2016年4月
SARCOPENIA AND THE MODIFIED GLASGOW PROGNOSTIC SCORE ARE SIGNIFICANT PREDICTORS OF PATIENT SURVIVAL IN METASTATIC RENAL CELL CARCINOMA PATIENTS RECEIVING FIRST-LINE SUNITINIB TREATMENT

Hiroki Ishihara, Tsunenori Kondo, Kenji Omae, Toshio Takagi, Jumpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe

JOURNAL OF UROLOGY 195(4) E330-E331 2016年4月
RISK FACTORS FOR ASYMPTOMATIC RENAL ARTERY PSEUDOANEURYSM AFTER PARTIAL NEPHRECTOMY DETECTED BY ENHANCED CT IN THE EARLY POSTOPERATIVE PERIOD

Toshio Takagi, Tsunenori Kondo, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe

JOURNAL OF UROLOGY 195(4) E837-E837 2016年4月
PROSTATE IMAGING REPORTING AND DATA SYSTEM SCORE BEFORE PROSTATE BIOPSY CAN PREDICT BIOCHEMICAL FAILURE IN PROSTATE CANCER PATIENTS TREATED WITH HIGH-DOSE-RATE BRACHYTHERAPY

Keisuke Hata, Junpei Iizuka, Yasunobu Hashimoto, Tsunenori Kondo, Toshio Takagi, Hirohito Kobayashi, Kazunari Tanabe

JOURNAL OF UROLOGY 195(4) E151-E151 2016年4月
腎腫瘍に対するロボット支援腹腔鏡下腎部分切除術と開腹腎部分切除術の周術期成績比較

高木敏男, 近藤恒徳, 吉田一彦, 大前憲史, 飯塚淳平, 小林博人, 橋本恭伸, 田邉一成

Japanese Journal of Endourology 28(3) 201-201 2015年11月
腎部分切除後腎動脈仮性動脈瘤発生のリスク因子の検討

高木敏男, 近藤恒徳, 大前憲史, 飯塚淳平, 小林博人, 橋本恭伸, 田邉一成

日本癌治療学会誌 50(3) 1870-1870 2015年9月
Tb腎腫瘍に対する腎部分切除術におけるrenorrhaphy法とnon-renorrhaphy法の手術成績の検証

高木敏男, 近藤恒徳, 大前憲史, 吉田一彦, 飯塚淳平, 小林博人, 橋本恭伸, 田邉一成

腎癌研究会会報 (45) 33-33 2015年7月
腎部分切除の現況と未来腎部分切除後の同一腎内局所再発に対する治療の考察

高木敏男, 近藤恒徳, 大前憲史, 飯塚淳平, 小林博人, 橋本恭伸, 田邉一成

泌尿器外科 28(臨増) 677-680 2015年5月
分子標的薬時代における転移性腎癌に対する転移巣切除の有効性についての検討

福田洋典, 近藤恒徳, 橋本恭伸, 小林博人, 飯塚淳平, 高木敏男, 大前憲史

泌尿器外科 28(臨増) 847-847 2015年5月
透析腎癌と散発性腎癌における臨床・病理学的特徴と癌特異的生存率の比較検討

高木敏男, 近藤恒徳, 飯塚淳平, 橋本恭伸, 大前憲史, 小林博人, 田邉一成

日本透析医学会雑誌 48(Suppl.1) 421-421 2015年5月
COMPARISON OF SURVIVAL RATES IN STAGE ONE RENAL CELL CARCINOMA BETWEEN PARTIAL NEPHRECTOMY AND RADICAL NEPHRECTOMY PATIENTS ACCORDING TO AGE DISTRIBUTION

Toshio Takagi, Tsunenori Kondo, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe

JOURNAL OF UROLOGY 193(4) E696-E696 2015年4月
TEMPLATE-BASED LYMPHADENECTOMY REDUCES THE RISK OF REGIONAL LYMPH NODE RECURRENCE IN PATIENTS WITH UPPER/MIDDLE URETERAL CANCER

Tsunenori Kondo, Isao Hara, Toshio Takagi, Yoshiki Kodama, Yasunobu Hashimoto, Hirohito Kobayashi, Junpei Iizuka, Kenji Omae, Kazuhiko Yoshida, Kazunari Tanabe

JOURNAL OF UROLOGY 193(4) E17-E17 2015年4月
THE RELATIONSHIP BETWEEN THE TIMING OF MAXIMUM TUMOR SHRINKAGE DURING 1ST-LINE TARGETED THERAPY AND OVERALL SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

Takafumi Yagisawa, Tsunenori Kondo, Kazuhiko Yoshida, Kenji Omae, Toshio Takagi, Junpei Iizuka, Hirohito Kobayashi, Yasunobu Hashimoto, Kazunari Tanabe

JOURNAL OF UROLOGY 193(4) E873-E873 2015年4月
尿管癌におけるリンパ節郭清の範囲とリンパ節再発および生存率に与える影響

近藤恒徳, 原勲, 高木敏男, 児玉芳季, 大前憲史, 橋本恭伸, 小林博人, 飯塚淳平, 池澤英里, 吉田一彦 …

日本泌尿器科学会総会 103回 465-465 2015年4月
スニチニブ2週投与1週休薬投与法で初期に休薬を要する患者のプロファイルの検討

齋藤直, 近藤恒徳, 高木敏男, 大前憲史, 小林博人, 橋本恭伸, 乾政志, 田邉一成

日本泌尿器科学会総会 103回 555-555 2015年4月
当院におけるロボット支援腹腔鏡下腎部分切除術の治療成績

若松太郎, 高木敏男, 大前憲史, 飯田祥一, 小林博人, 近藤恒徳, 田邉一成

日本泌尿器科学会総会 103回 763-763 2015年4月
T1b腎腫瘍に対するロボット補助下腹腔鏡下腎部分切除術の治療成績

高木敏男, 近藤恒徳, 大前憲史, 飯塚淳平, 小林博人, 橋本恭伸, 田邉一成

Japanese Journal of Endourology 27(3) 237-237 2014年11月

もっとみる

小林博人

基本情報

研究分野

論文

MISC

メニュー

共著者の一覧